What is Gestalt?
Gestalt Diagnostics is at the forefront of transforming anatomic pathology with its flagship platform, PathFlow. Building on prior success in developing a robust digital reading solution for radiology, now utilized in leading U.S. hospitals and processing over 13 million studies annually, Gestalt has adapted this proven technology into an enterprise-grade, cloud-based system. This platform is specifically engineered to meet the intricate needs and workflows of pathologists and pathology laboratories. By prioritizing digital workflow, interoperability, and scalable design, Gestalt equips laboratories, hospitals, and health systems with a comprehensive solution designed to elevate efficiency, accuracy, and collaboration throughout the pathology ecosystem.
How much funding has Gestalt raised?
Gestalt has raised a total of $14.4M across 3 funding rounds:
Debt
$150K
Series A
$7.5M
Private Equity
$6.7M
Debt (2020): $150K with participation from PPP
Series A (2025): $7.5M led by Inland Imaging, KickStart International, Tvf Fund 2, and Cowles Ventures
Private Equity (2025): $6.7M, investors not publicly disclosed
Key Investors in Gestalt
Inland Imaging
Inland Imaging is a provider of Radiology Services in the Northwest, with a mission guided by core purpose and values. Their subspecialty radiologists work with healthcare providers and hospitals to deliver fast, accurate diagnostic imaging.
KickStart International
KickStart International is a non-profit social enterprise dedicated to lifting millions of people in Africa out of poverty through cost-effective and sustainable solutions.
Tvf Fund 2
Tvf Fund 2 LLC operates within the Investment Banking industry, headquartered in Tacoma, Washington, and is involved in investment activities.
What's next for Gestalt?
The substantial enterprise-level funding and recent strategic investment signal a pivotal phase for Gestalt. This capital infusion is expected to accelerate the company's product development, expand its market reach, and further enhance its PathFlow platform. Gestalt is strategically positioned to capitalize on the growing demand for digital pathology solutions, aiming to set new industry standards for efficiency and diagnostic precision. The company's focus on modernizing anatomic pathology through technology suggests a future centered on deeper integration within healthcare systems and broader adoption by diagnostic facilities.
See full Gestalt company page
